A possible mechanism of action of thyrotropin-releasing hormone (TRH) and its analog DN-1417 on the release of dopamine from the nucleus accumbens and striatum in rats.
スポンサーリンク
概要
- 論文の詳細を見る
Slices of the nucleus accumbens, the terminus of the mesolimbic dopaminergic system and the striatum, the terminus of the nigrostriatal dopaminergic system obtained from rats, were used for analyzing the dopamine releasing effects of TRH and its analog DN-1417 (γ-butyrolactone-γ-carbonyl-L-histidyl-L-prolinamide citrate). (1) Dopamine release: The addition of DN-1417 (5×10<SUP>-5</SUP> M) or TRH (5×10<SUP>-4</SUP> M) stimulated the release of prelabelled [<SUP>3</SUP>H]-dopamine (DA) from the superfused nucleus accumbens slices, and 100 or 20 times higher concentrations of each compound stimulated DA release from the striatal slices. The omission of Ca<SUP>2+</SUP> from the superfusion medium or the addition of ouabain (5×10<SUP>-3</SUP> M), a (Na<SUP>+</SUP>+K<SUP>+</SUP>) stimulated adenosine triphosphate (ATP) phosphohydrolase [(Na<SUP>+</SUP>+K<SUP>+</SUP>)-ATPase] inhibitor, almost completely abolished the DN-1417 or TRH-induced DA releasing effect. (2) <SUP>45</SUP>Ca<SUP>2+</SUP> uptake: The addition of DN-1417 (10<SUP>-4</SUP> M) or TRH (10<SUP>-4</SUP> M) stimulated <SUP>45</SUP>Ca<SUP>2+</SUP> uptake into the nucleus accumbens slices in a time-dependent manner from 1 to 5 min at 30°C. On the other hand, both drugs (10<SUP>-4</SUP> M) had no effect on <SUP>45</SUP>Ca<SUP>2+</SUP> uptake into the striatal slices. A Ca<SUP>2+</SUP> ionophore, A-23187 (10<SUP>-6</SUP> M), stimulated <SUP>45</SUP>Ca<SUP>2+</SUP> uptake into slices of the nucleus accumbens and striatum. Ouabain abolished the DN-1417-, TRH- and A-23187-induced effects. (3) Cyclic AMP formation: The addition of DN-1417 (10<SUP>-4</SUP> M) or TRH (10<SUP>-4</SUP> and 10<SUP>-3</SUP> M) accelerated cyclic AMP formation in the nucleus accumbens, but not in the striatal slices. A Ca<SUP>2+</SUP> antagonist, methoxyverapamil (D-600, 10<SUP>-6</SUP> M) almost completely abolished the DN-1417 and TRH-effects. (4) (Na<SUP>+</SUP>+K<SUP>+</SUP>)-ATPase activity: The addition of DN-1417 (10<SUP>-5</SUP> and 10<SUP>-4</SUP> M) or TRH (10<SUP>-4</SUP> M) activated (Na<SUP>+</SUP>+K<SUP>+</SUP>)-ATPase in the P<SUB>1</SUB> fraction (cell debris, nuclei) of the nucleus accumbens, but had little effect on the same activity in the striatum. (5) [<SUP>3</SUP>H]-TRH binding: The addition of 10<SUP>-6</SUP> to 10<SUP>-4</SUP> M of DN-1417 and TRH inhibited concentration-dependently [<SUP>3</SUP>H]-TRH binding in the nucleus accumbens and striatal slices. Ouabain (5×10<SUP>-3</SUP> M) almost completely abolished [<SUP>3</SUP>H]-TRH binding in both types of slices. These results suggest that DN-1417 and TRH activate (Na<SUP>+</SUP>+K<SUP>+</SUP>)-ATPase and stimulate Ca<SUP>2+</SUP> uptake in the presynaptic sites and release DA which stimulates cyclic AMP formation in the postsynaptic sites of the mesolimbic dopaminergic system mainly and causes several central nervous actions.
- 公益社団法人 日本薬理学会の論文
著者
-
NARUMI SHIGEHIKO
Central Research Division, Takeda Chemical Industries, Ltd.
-
Nagawa Yuji
Central Research Division Takeda Chemical Industries Ltd.
-
Nagai Yasuo
Central Research Division Takeda Chemical Industries Ltd.
-
SAJI YOSHIAKI
Central Research Division, Takeda Chemical Industries Ltd.
関連論文
- MECHANISM OF ANTIPENTOBARBITAL ACTION OF THYROTROPIN-RELEASING HORMONE (TRH)
- BLOOD LEVEL AND BRAIN DISTRIBUTION OF THYROTROPIN-RELEASING HORMONE (TRH) DETERMINED BY RADIOIMMUNOASSAY AFTER INTRAVENOUS ADMINISTRATION IN RATS
- A TRH analog (DN-1417): Effects on local cerebral glucose utilization in conscious and pentobarbitalized rats determined by the autoradiographic 2-deoxy-(14C)glucose method.
- Increase in rat regional brain cyclic nucleotides by thyrotropin-releasing hormone (TRH) and its analog DN-1417.
- Effects of idebenone (CV-2619) on metabolism of monoamines, especially serotonin, in the brain of normal rats and rats with cerebral ischemia.
- Effects of TRH and an Analog, DN-1417 on the Activities of Single Neurons in the Nucleus Accumbens, Cerebral Cortex and Caudate-putamen of Rats
- Effects of idebenone (CV-2619) on endogenous monoamine release and cyclic AMP formation in diencephalon slices from rats.
- Pharmacologic characterization of a novel non-benzodiazepine selective anxiolytic, DN-2327.
- Beneficial effect of idebenone (CV-2619) on cerebral ischemia-induced amnesia in rats.
- A possible mechanism of action of thyrotropin-releasing hormone (TRH) and its analog DN-1417 on the release of dopamine from the nucleus accumbens and striatum in rats.
- In vivo electrochemical detection of 5-hydroxyindoles in the dorsal hippocampus of anesthetized rats treated with idebenone (CV-2619).